Posted on

Navidea Biopharmaceuticals is focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents. Navidea is actively developing two radiopharmaceutical agent platforms, Lymphoseek and RIGScan, designed to help identify the sites and pathways of undetected disease and improve diagnostic accuracy, clinical decision-making and ultimately patient care. In addition, Navidea has acquired the rights to develop a product for improved diagnosis of Alzheimer’s disease.